ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Nov 27, 2017 12:38 JST
Source:
Sisram Medical Ltd
Sisram Medical Ltd Increase in Shareholding by Controlling Shareholder and CEO As a Vote of Confidence and Trust in the Company's Future Success
HONG KONG, Nov 27, 2017 - (ACN Newswire) - Sisram Medical Ltd ("Sisram" or the "Company"; stock code: 1696.HK), an investment holding company specializing in medical technology for healthcare ranked #1 in the PRC and one of the top 5 global leaders in the industry, announced the increase in shareholding by the Company's controlling shareholder and CEO.
Ample Up Limited ("Ample Up"), controlling shareholder of Sisram, and Mr. Lior Moshe Dayan, Chief Executive Officer and Executive Director of Sisram, has acquired additional shares of the Company. According to latest announcements, Ample Up has made on-market purchase on The Stock Exchange of Hong Kong Limited ("SEHK") of an aggregate of 288,800 and 270,000 shares of the Company on 21 and 22 November 2017 respectively. Mr. Dayan has made on-market purchases on SEHK of an aggregate of 36,000 shares of the Company. After the increase in shareholding, Ample Up directly and indirectly controls approximately 52.83% and Mr. Dayan controls approximately 0.008% of the total issued shares of the Company.
In the first half of 2017, the Company's revenue was reported US$66.3 million, representing a year over year growth of 12.9%. The Company's adjusted net profit increased by 30.6% to US$13.3 million. The profitability and operational quality of the Company improved continuously. Sisram invest a lot of efforts in promoting its various brands, increasing market awareness and sales of its products, as well as expanding sales and distribution channels. The increase of shareholdings by the company's controlling shareholder and management expresses a vote of confidence in the company and its future roadmap.
Looking forward, Mr. Lior Moshe Dayan said, "Sisram is the first Israeli company listed on the main board of the Hong Kong Stock Exchange, with comprehensive in-house capabilities to design, develop and produce energy-based medical aesthetic treatment systems. In the past 3 years, more than 90% of our revenue was driven from products that we have developed in-house. Moving forward we are committed to significant investments in Research & Development that will produce innovative high-end products to meet the growing opportunities that the global market of energy-based medical aesthetic treatment solutions presents."
About Sisram Medical Ltd
Sisram Medical Ltd. (1696.HK), the first Israeli company listed on the Hong Kong Stock Exchange Main Board, is an investment holding company specializing in medical technology for healthcare. Among its holdings is Alma Lasers, a leading provider of energy-based surgical and medical aesthetic solutions, rating #1 in the Peoples Republic of China and one of the top 5 global leaders in its industry. Sisram Medical is a subsidiary of Fosun Pharma, a leading health & medical industry group in China.
Sisram Medical - Enhancing Quality of Life.
www.sisram-medical.com
Source: Sisram Medical Ltd
Sectors: Daily Finance, Healthcare & Pharm
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
Four-strong TOYOTA GAZOO Racing squad to push for more Portugal success
May 02, 2024 18:05 JST
Spectacular Spa awaits TOYOTA GAZOO Racing
May 02, 2024 17:46 JST
Q&M Dental Enhances Digital Capabilities by Integrating Align Technology's Newest iTero Lumina(TM) Intraoral Scanner Across Dental Clinics in Singapore
May 02, 2024 11:00 JST
Sumitomo Metal Mining and Mitsubishi Corporation to Participate in Kalgoorlie Nickel Project - Goongarrie Hub
Apr 30, 2024 19:08 JST
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg
Apr 30, 2024 18:00 JST
SPARX Group Establishes Space Frontiers Second Fund
Apr 29, 2024 18:49 JST
MHI Establishes Local Subsidiary "Mitsubishi Heavy Industries Vietnam"
Apr 29, 2024 18:00 JST
POSCO Future M and Honda Reach Basic Agreement on Collaboration for Production of Cathode Materials for Automotive Batteries in Canada
Apr 29, 2024 14:25 JST
Honda Plans to Establish Comprehensive Electric Vehicle Value Chain in Ontario, Canada
Apr 29, 2024 14:16 JST
JCB enables JCB Contactless acceptance at Taichung MRT in Taiwan
Apr 26, 2024 10:00 JST
Mazda Production and Sales Results for March 2024 and for April 2023 through March 2024
Apr 25, 2024 18:21 JST
MHI Begins Operation of SOEC Test Module the Next-Generation High-Efficiency Hydrogen Production Technology at Takasago Hydrogen Park
Apr 25, 2024 17:45 JST
GAC Honda to Begin Sales of All-new e:NP2, the Second Model of e:N Series
Apr 25, 2024 16:50 JST
Toyota Exhibiting at Beijing Motor Show 2024
Apr 25, 2024 16:25 JST
Honda Reaches Basic Agreement with Asahi Kasei on Collaboration for Production of Battery Separators for Automotive Batteries in Canada
Apr 25, 2024 11:10 JST
UNIQLO Sponsors KAWS + Warhol Exhibition Tour, Starting in Pittsburgh
Apr 25, 2024 09:00 JST
Mitsubishi Power Begins Commercial Operation of Seventh M701JAC Gas Turbine in Thailand GTCC Project; Achieves 75,000 AOH To-Date
Apr 24, 2024 17:19 JST
MC and Denka Sign J/V Agreement in Fullerene Business
Apr 24, 2024 17:02 JST
Mitsubishi Motors Posts Record Sales in the Philippines in FY2023
Apr 24, 2024 13:56 JST
NEC Develops High-speed Generative AI Large Language Models (LLM) with World-class Performance
Apr 24, 2024 13:25 JST
More Latest Release >>
Related Release
Sisram Med Presents its Best Annual Reports to Date
March 21 2018 08:30 JST
The New ALMA BEAUTY SPADEEP Platform Launched Globally After Receiving Outstanding Feedbacks in the Japanese Market
December 06 2017 16:34 JST
Sisram Med Revenue in First Half 2017 Increased 12.9% to US$66.3 Million
September 29 2017 18:31 JST
Net Proceeds of approximately HK$877.2 Million from Global Offering; Sisram Med Trading Debut on SEHK on 19 September 2017
September 20 2017 12:57 JST
Sisram Med Successfully Listed on Main Board of SEHK
September 20 2017 12:34 JST
Sisram Medical Offers price between HK$8.88 and HK$12.35 per share
September 05 2017 17:00 JST
More Press release >>